Changing how Lyme
disease is detected.
LymeAlert was created to make early detection more answering the question of what to do after a tick bite. Our solution is to test the tick for important data and informed decision-making.
Changing how Lyme
disease is detected.
LymeAlert was created to make early detection more answering the question of what to do after a tick bite. Our solution is to test the tick for important data and informed decision-making.
Our Mission
Improve access to healthcare through innovative home testing options.
Healthcare should not depend on timing, access, or chance. LymeAlert exists to make early detection accessible so you can act sooner, with clarity and confidence.
Building beyond a single test.
LymeAlert is building a broader platform for early detection, intelligence, and response to vector-borne disease. By combining testing, data, and mapping, the goal is to help identify risk earlier and support faster responses wherever exposure occurs.
Our vision
Our vision
Building beyond a single test.
LymeAlert is building a broader platform for early detection, intelligence, and response to vector-borne disease. By combining testing, data, and mapping, the goal is to help identify risk earlier and support faster responses wherever exposure occurs.
Our approach
Built on science, designed for early detection.
LymeAlert is built using lab-based detection principles to detect the pathogen that can cause Lyme disease in ticks. By focusing on early-stage exposure and testing the tick, it provides answers in minutes instead of days, helping people make faster, more informed decisions.
accessible, and easy to use.”
— Dr. Michelle Ewy, CSO & Co-founder
Our Team
A team across medical, science, data, and operations,
focused on making healthcare accessible and building a platform for early detection.
Erin Dawicki
CEO and Co-founder
Physician Associate with nearly two decades of clinical experience. She has held teaching and clinical roles at Boston Children’s Hospital, Tufts University School of Medicine, and in private practice.
Dr. Michelle Ewy
CSO and Co-founder
Scientist and Air Force veteran with 20+ years in chemistry, biotechnology, and diagnostic development.
Brenda Ong
COO and Co-founder
Operations and strategy leader with experience in public safety, government systems, and large-scale coordination.
Craig McLaughlin
CFO
CPA with more than a decade of experience in accounting, tax, financial planning, and the public sector finance leadership.
Lewis Shotton
Lead Researcher and Co-founder
Bioengineer and researcher with experience in material synthesis and lateral flow assay development for disease detection.
Susanna Keeton
Product Leader
Product leader focused on turning early innovation into market-ready solutions and successful launches.
Casey Tilli
CMO
Marketing executive with 20+ years of experience leading campaigns, partnerships, growth, and brand launches.
Carissa Qiu
Business Development Intern
MIT student in finance and economics, supporting business development.
Advisory Board
Our advisory board includes leaders across biotechnology,
veterinary medicine, public health, and research.
Mark Reilly, DVM
Owner of South Shore Equine Hospital and Author of “Lyme disease in Horses.”
Marjorie Radlo-Zandi, MBA
Entrepreneur and Investor Board Member of QSM Diagnostics.
Charlie Cooney, PhD
MIT Prof Emeritus, Chemical Engineering Founder, Consultant & Board Member of multiple Biotech companies.
John van Amsterdam, PhD
Biotech Lawyer Shareholder at Wolf Greenfield, Biotech Practice Expertise.
Michelle Chao, BEng
Co-founder, Phoenix Tailings, Forbes 30 under 30.
Jane Karol, PsyD
Owner of Bear Spot Farm Equine Industry Leader.
Rohini Kumar
Marketing expert with success driving retail, brand, and product marketing for Target, Disney, and Atlassian.
Rohini Kumar
Marketing expert with success driving retail, brand, and product marketing for Target, Disney, and Atlassian.
In the News
Making headlines for Crushing Lyme disease one tick at a time.
Supported By
Don’t wait for symptoms.
Take action early.
Turn uncertainty into clarity in minutes.